Genetic profiling of different phenotypic subsets of breast cancer stem cells (BCSCs) in breast cancer patients
Authors (first, second and last of 6)
Volume 22, issue 1, December 2022
423 articles in this issue
-
-
Knock down of TIMP-2 by siRNA and CRISPR/Cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer
Authors (first, second and last of 7)
This is part of 1 collection:
-
Targeting hyaluronic acid synthase-3 (HAS3) for the treatment of advanced renal cell carcinoma
Authors (first, second and last of 18)
-
Interactions of melatonin with various signaling pathways: implications for cancer therapy
Authors (first, second and last of 4)
-
Rise of the natural red pigment ‘prodigiosin’ as an immunomodulator in cancer
Authors (first, second and last of 4)
-
Establishment and characterization of a new intrahepatic cholangiocarcinoma cell line derived from a Chinese patient
Authors (first, second and last of 8)
-
Therapeutic effect of a MUC1-specific monoclonal antibody-drug conjugates against pancreatic cancer model
Authors (first, second and last of 11)
-
Transition of amyloid/mutant p53 from tumor suppressor to an oncogene and therapeutic approaches to ameliorate metastasis and cancer stemness
Authors (first, second and last of 5)
-
Increased expression of miR-194-5p through the circPVRL3/miR-194-5p/SOCS2 axis promotes proliferation and metastasis in pancreatic ductal adenocarcinoma by activating the PI3K/AKT signaling pathway
Authors (first, second and last of 13)
-
Mass spectrometry imaging in gynecological cancers: the best is yet to come
Authors (first, second and last of 7)
-
Membrane protein trafficking in the anti-tumor immune response: work of endosomal-lysosomal system
Authors
This is part of 1 collection:
-
-
Cell senescence-associated genes predict the malignant characteristics of glioblastoma
Authors (first, second and last of 6)
-
Retraction Note: LINC01089 functions as a ceRNA for miR-152-3p to inhibit non‐small lung cancer progression through regulating PTEN
Authors (first, second and last of 6)
-
Retraction Note: Knockdown of circRNA_0007534 suppresses the tumorigenesis of cervical cancer via miR-206/GREM1 axis
Authors (first, second and last of 4)
-
-
Natural essential oils as a new therapeutic tool in colorectal cancer
Authors (first, second and last of 18)
-
Retraction Note: Circ_002117 binds to microRNA-370 and promotes endoplasmic reticulum stress-induced apoptosis in gastric cancer
Authors (first, second and last of 6)
-
Gaseous nitric oxide tumor ablation induces an anti-tumor abscopal effect
Authors (first, second and last of 16)
-
Oleic acid from cancer-associated fibroblast promotes cancer cell stemness by stearoyl-CoA desaturase under glucose-deficient condition
Authors (first, second and last of 4)
-
-
Regulation of mitochondrial complex III activity and assembly by TRAP1 in cancer cells
Authors (first, second and last of 12)
-
Clinical potential of PD-1/PD-L1 blockade therapy for renal cell carcinoma (RCC): a rapidly evolving strategy
Authors (first, second and last of 8)
-
Transcriptomic landscape of TIMP3 oncosuppressor activity in thyroid carcinoma
Authors (first, second and last of 9)
-
Ursolic acid: a natural modulator of signaling networks in different cancers
Authors (first, second and last of 11)
-
Lyve-1 deficiency enhances the hepatic immune microenvironment entailing altered susceptibility to melanoma liver metastasis
Authors (first, second and last of 15)
-
The metastatic capacity of high-grade serous ovarian cancer cells changes along disease progression: inhibition by mifepristone
Authors (first, second and last of 4)
-
LncRNA HOTAIR impairs the prognosis of papillary thyroid cancer via regulating cellular malignancy and epigenetically suppressing DLX1
Authors (first, second and last of 12)
-
Involvement of abnormal dystroglycan expression and matriglycan levels in cancer pathogenesis
Authors
-
Current methods for studying metastatic potential of tumor cells
Authors
This is part of 1 collection:
-
CD5L-associated gene analyses highlight the dysregulations, prognostic effects, immune associations, and drug-sensitivity predicative potentials of LCAT and CDC20 in hepatocellular carcinoma
Authors (first, second and last of 9)
-
Potential of Z-100, extracted from Mycobacterium tuberculosis strain Aoyama B, as a hot tumor inducer
Authors (first, second and last of 8)
-
Evaluation of X-ray and carbon-ion beam irradiation with chemotherapy for the treatment of cervical adenocarcinoma cells in 2D and 3D cultures
Authors (first, second and last of 11)
-
Exosomal LINC00460/miR-503-5p/ANLN positive feedback loop aggravates pancreatic cancer progression through regulating T cell–mediated cytotoxicity and PD-1 checkpoint
Authors (first, second and last of 13)
-
Glioblastoma cells have increased capacity to repair radiation-induced DNA damage after migration to the olfactory bulb
Authors (first, second and last of 6)
-
BI-847325, a selective dual MEK and Aurora kinases inhibitor, reduces aggressive behavior of anaplastic thyroid carcinoma on an in vitro three-dimensional culture
Authors (first, second and last of 7)
-
The anterior gradient homologue 2 (AGR2) co-localises with the glucose-regulated protein 78 (GRP78) in cancer stem cells, and is critical for the survival and drug resistance of recurrent glioblastoma: in situ and in vitro analyses
Authors (first, second and last of 15)
-
Luteolin: a flavonoid with a multifaceted anticancer potential
Authors (first, second and last of 11)
-
METTL3 promotes glycolysis and cholangiocarcinoma progression by mediating the m6A modification of AKR1B10
Authors (first, second and last of 7)
-
Correction: FOXM1-induced TYMS upregulation promotes the progression of hepatocellular carcinoma
Authors (first, second and last of 4)
-
Landmarks in pancreatic cancer studies
Authors (first, second and last of 8)
This is part of 1 collection:
-
Identification and validation of an E2F-related gene signature for predicting recurrence-free survival in human prostate cancer
Authors (first, second and last of 8)
-
Role of microRNA-34b-5p in cancer and injury: how does it work?
Authors (first, second and last of 5)
-
HDACs/mTOR inhibitor synergizes with pyrotinib in HER2-positive pancreatic cancer through degradation of mutant P53
Authors (first, second and last of 11)
-
Are chemical compounds in medical mushrooms potent against colorectal cancer carcinogenesis and antimicrobial growth?
Authors (first, second and last of 10)
-
Exosomal circular RNA: a signature for lung cancer progression
Authors (first, second and last of 8)
-
NRP1 inhibition modulates radiosensitivity of medulloblastoma by targeting cancer stem cells
Authors (first, second and last of 8)
-
Identifying novel interactions of the colon-cancer related APC protein with Wnt-pathway nuclear transcription factors
Authors (first, second and last of 5)
-
Transcription factor c-Rel regulated by E5 affects the whole process after HPV16 infection through miR-133a-modulated feedback loop aim at mir-379-369 cluster
Authors (first, second and last of 8)
-
Multidrug resistance genes screening of pancreatic ductal adenocarcinoma based on sensitivity profile to chemotherapeutic drugs
Authors (first, second and last of 9)
